ecancer

ECCO 15 - ESMO 34 News 23rd September 2009

Prof Gordon McVie - ecancer Managing Editor

23 Sep 2009

ECCO 15 - ESMO 34 News 22nd September 2009

Prof Gordon McVie - ecancer Managing Editor

22 Sep 2009

ECCO 15 - ESMO 34 News 20-21 September, 2009

Prof Gordon McVie - ecancer Managing Editor

21 Sep 2009

Translational research - a contribution to future cancer treatment

Prof Otmar Wiestler - Heidelberg University, Germany

21 Sep 2009

Personalised breast cancer therapy and the ALLTO trial

Dr Joanne Zujewski - Head of Breast Cancer Therapeutics, NCI, USA

16 Sep 2009

The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues

ECCO 15 - ESMO 34

22 Jul 2009

ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?

Why attend ECCO 15 - ESMO 34?

22 Jul 2009

PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer

Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US

3 Jul 2009

Targeting death receptors in chemo-resistant cancer cells

Prof Patrick Johnston - Queen's University Belfast, UK

3 Jul 2009

Zoledronic acid for treament of prostate cancer

Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals

25 Jun 2009

ASCO: Impact of common antidepressants on tamoxifen effectiveness

Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands

18 Jun 2009

AACR 2009: Circulating tumour cells as biomarkers

Dr Howard Scher - Sloan Kettering Memorial Cancer Center

5 Jun 2009

More from ecancer